Summit Therapeutics officers investigated for possible shareholder duty breaches and self-dealing.

Kuehn Law, PLLC is investigating whether certain officers and directors of Summit Therapeutics Inc. breached their fiduciary duties to shareholders through potential self-dealing. This legal probe could lead to damages for shareholders and reforms in corporate governance. Long-term shareholders are encouraged to contact the law firm for a free consultation to explore their rights and possible claims. The investigation highlights concerns about management's integrity and the protection of investor interests at Summit Therapeutics.